Please provide your email address to receive an email when new articles are posted on . Prophylactic inferior vena cava filter placement declined in the United States from 2005 to 2014, but rates ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

The patient with both recent bleeding and thrombotic events poses a great challenge to clinicians. The rationale for an IVC filter is that it would potentially reduce the risk of morbid or fatal ...

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava filters -- devices used to keep blood clots from ...

Effect of tolfenamic acid on ovarian cancer cell growth, targeting of specificity protein transcription factors, and expression of c-Met and survivin. Background: Venous thrombosis is a frequent ...

Use of inferior vena cava (IVC) filters declined in the United States following a 2010 safety communication from the US Food and Drug Administration (FDA), although the rate of implantation remains ...

Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained. Of 182 patients, 103 were men and 79 were women. Median age was 59 years (range, 15 to 88 ...

Cancer patients with blood clots -- which occur in one of every 200 cancer patients and are the second most common cause of death among cancer patients -- gain no benefit from the insertion of an ...

Getty Images It is imperative to consider the potential life-saving benefits of IVC ligation despite the higher incidence of associated complications. In the largest multicenter study of factors ...